Pharmaceutical Technology
November 02, 2010
In the Spotlight
34
11
Editors' picks of pharmaceutical science and technology innovations.
November 02, 2010
Ingredients Insider
34
11
Abuse-deterrent combination drugs represent a niche area in formulation development.
November 02, 2010
Inside USP
34
11
USP is working to ensure quality standards and to increase public information.
November 02, 2010
Online Exclusives
34
11
A recent book offers an excellent overview of cleaning validation.
November 02, 2010
News
34
11
IP rights and levels of innovation have opened a bit of controversy regarding decisions being made by Indian courts and legislators.
November 02, 2010
Special Report
34
11
An analysis of the approaches and tools used to tackle the problem of poorly soluble drugs.
November 02, 2010
Ingredients Insider
34
11
Industrial and academic partnerships forge new territory in solid-state chemistry.
November 02, 2010
Special Report
34
11
A conversation with Mike de la Montaigne, president of Eisai Machinery, USA Inc., about the possibilities for conducting fully automated product inspections.
November 02, 2010
Guest Editorial
34
11
As technology advances, industry's needs are growing.
November 02, 2010
Viewpoint
34
11
Scientists and practitioners must work together for the overall good of the patient.
November 02, 2010
Washington Report
34
11
A new center may provide evidence for improving care, but could discourage coverage of treatments.
November 02, 2010
Peer-Reviewed
34
11
The authors describe a modified version of the Large-N test used to determine content uniformity.
November 02, 2010
Special Report
34
11
A Q&A with officers of the departments of State Food and Drug Administration, China, moderated by Ji Xie.
November 02, 2010
Peer-Reviewed
34
11
The authors describe the development of an inclusion complex of GLZ and formulated an extended-release dosage form based on osmotic technology.
November 02, 2010
Insider Solutions
34
11
Drug manufacturers have to be more than just "audit ready."
November 02, 2010
Agent-in Place
34
11
Remaining calm, cool, and collected during mergers and inspections is a feat in itself.
November 02, 2010
Featured Content
34
11
The author examines the process of method development, with reference to ISO 13320:2009 and relevant monographs from the United States and European pharmacopoeias.
November 02, 2010
Online Exclusives
34
11
The authors discuss gamma scintigraphy as a technique for in vivo evaluation of drugs and delivery systems.
November 02, 2010
Peer-Reviewed
34
11
The authors demonstrated that ODTs can be obtained by direct compression of a mixture of starch, fructose, and SMCC.
November 02, 2010
News
34
11
Merck and AstraZeneca Tackle Cervical Cancer and Tuberculosis.
November 02, 2010
Outsourcing Outlook
34
11
Post recession and beyond, which contract service providers will still be standing?
November 02, 2010
PharmTech Talk
34
11
Connecting science and policy might increase support for innovation.
November 02, 2010
Packaging Forum
34
11
Used packaging equipment can be a cost-saving, time-saving alternative to new machines.
November 02, 2010
Featured Content
34
11
The authors present an update to the Wyeth/BASF experience with the IPEC Novel Excipient Safety Evaluation Procedure.
November 02, 2010
Industry Leaders
34
11
Stuart Needleman, president of active-ingredient development and manufacturing at Aptuit, discusses industry trends and challenges.
November 02, 2010
Statistical Solutions
34
11
Applied statisticians are forever searching for the enemy of quality-variability.
November 01, 2010
Issue PDF
34
11
Solubilizing the Insoluble